Simple blood test may forecast lung Cancer's return
NCT ID NCT07170046
First seen Oct 31, 2025 · Last updated May 23, 2026 · Updated 25 times
Summary
This study looks at whether measuring CEA and ctDNA in the blood can help predict if lung cancer will return after surgery. Researchers will follow 100 patients with high CEA levels before surgery, tracking their blood markers for two years. The goal is to catch recurrence earlier and personalize treatment, potentially saving time and costs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.